Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often highlight the opportunity for substantial therapeutic benefits, principally in conditions where conventional medications have proven limited. However, this is to evaluate the significant financial burden associated with CPI stem cell